While the Trump administration has not publicly identified the drugmakers and biotechs involved in Operation Warp Speed – its effort to have 300 million doses of a safe and effective COVID-19 vaccine ready by January 2021 – some tiny biotechs have been touting their involvement in the program, sending their stocks soaring. For more, CLICK HERE.
![](https://www.zenmoneynews.com/wp-content/uploads/2023/04/003-Finance-and-Stock-Chart-man-with-coffee.jpeg)